Supportive Oncology Journal Articles and Videos
Can we Continue to Afford Access to Cancer Treatment?
European Oncology & Haematology, 2017;13(2):114–9 DOI: https://doi.org/10.17925/EOH.2017.13.02.114
What Happens when the Cost of Cancer Care Becomes Unsustainable?
European Oncology & Haematology, 2017;13(2):108–13 DOI: https://doi.org/10.17925/EOH.2017.13.02.108
Potential Solutions for Sustaining the Costs of Cancer Drugs
European Oncology & Haematology, 2017;13(2):102–7 DOI: https://doi.org/10.17925/EOH.2017.13.02.102
Rolapitant in the Current Management of Chemotherapy-induced Nausea and Vomiting
European Oncology & Haematology, 2017;13(2):120–6 DOI: https://doi.org/10.17925/EOH.2017.13.02.120
Specialist Physician and Medical Oncologist at The Medical Oncology Centre in Rosebank, Johannesburg, South Africa
Dr Rapoport has presented more than 100 abstracts at South African and international meetings (including ASCO, MASCC and ESMO) and published more than 60 peer reviewed publications with over 2,000 citations. He is a reviewer for numerous scientific medical journals, including Annals of Oncology, Supportive Care in Cancer and Journal of Clinical Oncology.
His fields of interest include cancer supportive care, antiemetics and infections in cancer, breast cancer, solid tumours and new anticancer agents. Dr Rapoport is a member of numerous professional societies, including the South African Society of Medical Oncology (SASMO), the European Society for Medical Oncology (ESMO), the American Society for Medical Oncology (ASCO) and the Multinational Association for Supportive Care in Cancer (MASCC), Chair of the MASCC Infection and Myelosupression Study Group and a member of the MASCC Antiemetic Guidelines Working Group and the MASCC Skin Toxicity Study Group. He is a member of various South African and international pharmaceutical company Advisory Boards as well as Protocol Steering Committee.